Clopidogrel High Dose Evaluation for the Patient With Coronary Artery Disease in Japan

NCT01069302 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

106

Enrollment

OTHER

Sponsor class

Conditions

Coronary Artery Disease

Interventions

DRUG: Clopidogrel
DRUG: Clopidogrel
DRUG: Clopidogrel
DRUG: Clopidogrel

Sponsor

Takeshi Morimoto